Discover Verastem Inc (VSTM) market and community sentiment, movement in message volume, participation score and buzz level in the Stocktwits communityVerastem Oncology is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index. Wikipedia. Headquarters: Massachusetts. CEO: Brian Stuglik (Jul 2019-)BOSTON--(BUSINESS WIRE)--Jun. 16, 2023-- Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the pricing of an underwritten public offering of 7,181,409 shares of its common stock at a price to the public of $9.75 per share and, in lieu of common stock to certain investors, pre-funded warrants to purchase ...Reminiscent of a favorite grilled steak from a local Chinese restaurant, this burger is for ginger lovers. Do not substitute dried ginger for the fresh: unless you are baking, drie...Mar 14, 2024 · BOSTON, March 14, 2024--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today reported financial results for the three ...Latest VERASTEM (VSTM) stock news, Verastem, Inc., operating as Verastem Oncology, is a biopharmaceutical company focusing on developin... Close. Discover the power of a Real-Time Financial News Database! ... Import your watchlist from Stocktwits and get a realtime overview of all news articles published regarding your favorite symbols ...However, these revenue estimates do illustrate how Verastem could go from pulling just over $2M to over $200M in just five years, which would be a roughly 0.4x forward price-to-sales. The industry ...GFH375/VS-7375. GFH375/VS-7375 is an orally bioavailable, potent and selective small molecule KRAS G12D (ON/OFF) inhibitor. Preclinical models demonstrate strong tumor regression as a single agent and support approaches in combination with Verastem Oncology’s RAF/MEK clamp avutometinib as well as other rational combinations across …Verastem, Inc. Common Stock (VSTM) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.BOSTON -- (BUSINESS WIRE)--Jan. 6, 2021-- Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced the appointment of industry veteran Frank Neumann, M.D., Ph.D., as Chief Medical Officer to oversee the Company's clinical and ...Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.Summary. Verastem's stock plummeted after updates showed reduced efficacy in cancer treatment trials, causing a reassessment of strategy. Updated clinical …Verastem Oncology (Nasdaq: VSTM) is a commercial biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and ...Investors: Ajay Munshi Vice President, Corporate Development +1 781-469-1579 [email protected] Sherri Spear Argot Partners +1 212-600-1902 [email protected] Media: Lisa Buffington ...Track Taiwan Semiconductor Manufacturing - ADR (TSM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsSome Amazon staff began distributing Slack and email messages on Monday calling for other workers to join the protest, The Washington Post reported. Jump to Some Amazon employees i...Track Atlassian Corporation Plc (TEAM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsThe forward-looking statements contained in this press release reflect Verastem Oncology’s views as of the date hereof, and Verastem Oncology does not assume and specifically disclaims any obligation to update any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law.Find the latest Verastem, Inc. (VSTM) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.The latest price target for Verastem ( NASDAQ: VSTM) was reported by HC Wainwright & Co. on Monday, May 13, 2024. The analyst firm set a price target for 17.50 expecting VSTM to rise to within 12 ...Track Sabre Corp (SABR) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem recently publicized updated data from the Part A portion of their registration-directed RAMP 201 Phase II trial of Avutometinib "VS-6766" as a monotherapy or in combination with ...Shares of Verastem rallied 6.15% in after-hours trading following this Chinese deal. In fact, so far this year, the stock has skyrocketed 132.9% against the industry's decline of 2.7%.Reparto Universitario Reparto Universitario is a village in Santiago De Los Caballeros (Zona Urbana), Santiago de los Caballeros, Santiago Province.Reparto Universitario is situated close to the neighborhoods La Zurza and La Loteria.About Verastem Oncology. Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that ...Verastem Oncology Announces Initiation of a Confirmatory Phase 3 Trial of Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer. BOSTON-- (BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM) (the “Company”), a biopharmaceutical company committed to advancing new medicines for patients with cancer, announced today that it has ...Track T2 Biosystems Inc (TTOO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival ...Track Novo Nordisk A/S (NVO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsStock analysis for Verastem Inc (VSTM:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Fintel reports that on June 27, 2023, Truist Securities reiterated coverage of Verastem ( NASDAQ:VSTM) with a Buy recommendation. Analyst Price Forecast Suggests 393.85% Upside. As of June 2, 2023 ...Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed ...Analysts Offer Insights on Healthcare Companies: Verastem (VSTM), ANI Pharmaceuticals (ANIP) and Argenx Se (ARGX) May 13, 2024TipRanks. RBC Capital Sticks to Their Buy Rating for Verastem (VSTM ...Verastem, Inc. is a late-stage development biopharmaceutical company. The Company's pipeline is focused on anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) inhibition and focal adhesion kinase (FAK) inhibition.Free VSTM Stock Alerts. $11.50. -0.63 (-5.19%) (As of 05/17/2024 08:54 PM ET) Compare. Share. Stock Analysis Analyst Forecasts Chart Competitors Earnings Financials Headlines Insider Trades Options Chain Ownership SEC Filings Short Interest Social Media. Media Mentions Over Time. 10.Track Sagimet Biosciences Inc (SGMT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem Oncology. Reconciliation of GAAP to Non-GAAP Financial Information (in thousands, except per share amounts) (unaudited) Three months ended September 30, Nine months ended September 30, 2023 2022 2023 2022. Net loss reconciliation Net loss (GAAP basis) $ (20,004 ) $ (18,090 ) ...View the latest Verastem Inc. (VSTM) stock price, news, historical charts, analyst ratings and financial information from WSJ.Committee Composition. Below is a summary of our committee structure and membership information. To read more about any of the committees, click on committee names in the chart below. Board of Directors. Audit Committee. Compensation Committee. Nominating and Corporate Governance Committee. Research and Development Committee.Track SeaStar Medical Holding Corp (ICU) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsBOSTON--(BUSINESS WIRE)--Jul. 27, 2021-- Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced that an abstract detailing updated results from the ongoing Phase 1/2 FRAME study investigating VS-6766, the Company's RAF/MEK inhibitor, in combination with defactinib, its FAK inhibitor, in patients with ...According to 4 analyst offering 12-month price targets in the last 3 months, Verastem has an average price target of $28.0 with a high of $36.00 and a low of $21.00.Verastem Oncology (NASDAQ:VSTM) has received FDA orphan drug designation for its drug candidate avutometinib for the treatment of a rare cancer.The orphan drug status was assigned to avutometinib ...Consensus Verastem, Inc. Equities VSTM US92337C2035 Market Closed - Nasdaq. Other stock markets. 04:00:00 2024-05-10 pm EDT 5-day change 1st Jan Change 11.85 USD -0.59% +8.72% +45.58%: May. 09: Verastem, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI ...This press release includes forward-looking statements about Verastem Oncology's strategy, future plans and prospects, including statements related to the potential clinical value of various of its clinical trials, the timing of commencing and completing trials, including topline data reports, interactions with regulators and potential for ...Track Advanced Micro Devices Inc (AMD) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem Oncology (Nasdaq: VSTM) is a commercial biopharmaceutical company committed to the development and commercialization of medicines to improve the lives of patients diagnosed with cancer. We are driven by the strength, tenacity and courage of those battling cancer - single-minded in our resolve to deliver new therapies that not only ...2 days ago · 6 equities research analysts have issued 1 year price objectives for Verastem's shares. Their VSTM share price targets range from $17.50 to $36.00. On average, they expect the company's share price to reach $28.79 in the next year. This suggests a possible upside of 598.7% from the stock's current price.Track Vertiv Holdings Co - Ordinary Shares - Class A (VRT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVSTM News. 1 day ago - Verastem opened 70% down on Friday: what happened? - Invezz ; 1 day ago - Harvest ETFs announces May 2024 Distributions - Business Wire 1 day ago - Verastem Oncology Announces the Initiation of a Rolling Submission of NDA to FDA Seeking Accelerated Approval of Avutometinib and Defactinib Combination for the Treatment of Adult Patients with Recurrent KRAS Mutant Low-Grade ...VSTM Stock 12 Months Forecast. $31.67. (187.91% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Verastem in the last 3 months. The average price target is $31.67 with a high forecast of $36.00 and a low forecast of $27.00. The average price target represents a 187.91% change from the last price of $11.00.Track Meta Platforms Inc (META) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack Inspire Veterinary Partners Inc. - Ordinary Shares - Class A (IVP) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsBrian Stuglik, RPh. Mr Stuglik served as the Chief Executive Officer (CEO) of Verastem Oncology from 2019 through 2023. Mr Stuglik is a global leader in the oncology pharmaceutical sector, having successfully developed, acquired, and launched several important oncology products across multiple tumor types and therapeutic approaches in his more ...Track Aptose Biosciences Inc (APTO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack Vertical Aerospace Ltd (EVTL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsThe Verastem stock price fell by -66.17% on the last day (Friday, 24th May 2024) from $12.18 to $4.12. During the last trading day the stock fluctuated 30.60% from a day low at $4.02 to a day high of $5.25. The price has been going up and down for this period, and there has been a -65.23% loss for the last 2 weeks.Discover Verastem Inc (VSTM) market and community sentiment, movement in message volume, participation score and buzz level in the Stocktwits communityThe stock options have an exercise price equal to $8.30 per share, the closing price of Verastem Oncology's common stock as reported by Nasdaq on January 2, 2024.Track Palantir Technologies Inc (PLTR) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.. Track Rumble Inc (RUM) Stock Price, Quote, latest Verastem saw a increase in short interest in the mont Find the latest Lexicon Pharmaceuticals, Inc. (LXRX) stock quote, history, news and other vital information to help you with your stock trading and investing. Verastem, Inc. is a late-stage development b This press release includes forward-looking statements about Verastem Oncology’s strategy, future plans and prospects, including statements related to cash runway, the potential clinical value of various of its clinical trials, the timing of commencing and completing trials, including topline data reports, and potential for additional …Economist Nouriel Roubini said Credit Suisse needs a liquidity lifeline from central banks — and the Swiss National Bank just agreed a $54 billion loan. Jump to Credit Suisse could... Adaptimmune Therapeutics ( ADAP 3.96%), Corvus...
Continue Reading